Working... Menu
Trial record 1 of 1 for:    NCT02401542
Previous Study | Return to List | Next Study

Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma (FIERCE-21)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02401542
Recruitment Status : Active, not recruiting
First Posted : March 30, 2015
Last Update Posted : April 10, 2019
Information provided by (Responsible Party):
Rainier Therapeutics

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : March 2021
  Estimated Study Completion Date : December 2021